Detalhe da pesquisa
1.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell
; 171(2): 481-494.e15, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985567
2.
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Blood
; 139(12): 1863-1877, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932792
3.
Clinical significance of gene defects in B-cell lymphomas.
Duodecim
; 133(9): 839-46, 2017.
Artigo
em Fi
| MEDLINE | ID: mdl-29239593
4.
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma.
Blood Cancer Discov
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630892
5.
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.
Med
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579729
6.
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.
Blood Adv
; 8(2): 407-415, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113470
7.
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
Semin Hematol
; 60(3): 132-141, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37455222
8.
Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma.
Haematologica
; 102(5): e195-e198, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183850
9.
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma.
Blood Adv
; 4(15): 3742-3753, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780847
10.
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.
Blood Adv
; 4(9): 1906-1915, 2020 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380536
11.
Immunogenomic Landscape of Hematological Malignancies.
Cancer Cell
; 38(3): 380-399.e13, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649887
12.
Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes.
Leukemia
; 33(11): 2662-2672, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186494
13.
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.
EJHaem
; 2(1): 104-108, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846101
14.
Immunogenomic Landscape of Hematological Malignancies.
Cancer Cell
; 38(3): 424-428, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931743